Wilbanks Smith & Thomas Asset Management’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-35,000
| Closed | -$138K | – | 514 |
|
|
2021
Q1 | $138K | Hold |
35,000
| – | – | 0.01% | 455 |
|
|
2020
Q4 | $82K | Hold |
35,000
| – | – | ﹤0.01% | 429 |
|
|
2020
Q3 | $76K | Hold |
35,000
| – | – | ﹤0.01% | 386 |
|
|
2020
Q2 | $72K | Hold |
35,000
| – | – | ﹤0.01% | 387 |
|
|
2020
Q1 | $47K | Hold |
35,000
| – | – | ﹤0.01% | 365 |
|
|
2019
Q4 | $121K | Hold |
35,000
| – | – | 0.01% | 407 |
|
|
2019
Q3 | $108K | Hold |
35,000
| – | – | 0.01% | 409 |
|
|
2019
Q2 | $106K | Hold |
35,000
| – | – | 0.01% | 404 |
|
|
2019
Q1 | $93K | Hold |
35,000
| – | – | 0.01% | 403 |
|
|
2018
Q4 | $107K | Hold |
35,000
| – | – | 0.01% | 346 |
|
|
2018
Q3 | $138K | Hold |
35,000
| – | – | 0.01% | 474 |
|
|
2018
Q2 | $109K | Hold |
35,000
| – | – | 0.01% | 339 |
|
|
2018
Q1 | $89K | Hold |
35,000
| – | – | 0.01% | 339 |
|
|
2017
Q4 | $93K | Hold |
35,000
| – | – | 0.01% | 339 |
|
|
2017
Q3 | $91K | Hold |
35,000
| – | – | 0.01% | 334 |
|
|
2017
Q2 | $200K | Hold |
35,000
| – | – | 0.02% | 320 |
|
|
2017
Q1 | $287K | Hold |
35,000
| – | – | 0.02% | 244 |
|
|
2016
Q4 | $184K | Hold |
35,000
| – | – | 0.02% | 296 |
|
|
2016
Q3 | $133K | Hold |
35,000
| – | – | 0.01% | 281 |
|
|
2016
Q2 | $137K | Hold |
35,000
| – | – | 0.01% | 280 |
|
|
2016
Q1 | $115K | Hold |
35,000
| – | – | 0.01% | 277 |
|
|
2015
Q4 | $103K | Hold |
35,000
| – | – | 0.01% | 272 |
|
|
2015
Q3 | $112K | Buy |
+35,000
| New | +$127K | 0.02% | 262 |
|
Wilbanks Smith & Thomas Asset Management's CRHM Position: Q2 2021 in Review
Wilbanks Smith & Thomas Asset Management sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 35,000 shares — an estimated $138K sold.
Wilbanks Smith & Thomas Asset Management first reported a position in CRHM in Q3 2015 and held it in 23 quarters. The position peaked at $287K in Q1 2017. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- Wilbanks Smith & Thomas Asset Management reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Wilbanks Smith & Thomas Asset Management sold 35,000 CRH Medical Corporation shares in Q2 2021, an estimated $138K.
- Wilbanks Smith & Thomas Asset Management first reported a position in CRH Medical Corporation in Q3 2015 and held it in 23 quarters.
- Wilbanks Smith & Thomas Asset Management's CRH Medical Corporation position peaked at $287K in Q1 2017.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.